| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | IHC:1/100-1/200;IHF:1/50-1/200 | Human,Mouse,Rat |
| ICC | 1/50-1/200 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | 15 hydroxyprostaglandin dehydrogenase [NADP+]; Carbonyl reductase [NADPH] 1; CBR1; CRN; NADPH dependent carbonyl reductase 1; Prostaglandin 9 ketoreductase; SDR21C1;;CBR1 |
| WB Predicted band size | 30 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | A synthesized peptide derived from human CBR1 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于CBR1抗体的3篇参考文献的简要概括(注：文献信息为模拟示例，实际文献需通过数据库检索获取)：
---
1. **文献名称**：*"Immunohistochemical Analysis of Carbonyl Reductase 1 in Colorectal Cancer Tissues"*
**作者**：Tanaka A, et al.
**摘要**：本研究利用特异性CBR1抗体对结直肠癌组织进行免疫组化分析，发现CBR1蛋白在肿瘤细胞中显著高表达，且与化疗药物伊立替康的耐药性相关，提示CBR1可能作为预测化疗反应的潜在标志物。
---
2. **文献名称**：*"Development of a Monoclonal Antibody for Human CBR1 and Its Application in Metabolic Studies"*
**作者**：Zhang Y, et al.
**摘要**：作者开发了一种高特异性人源CBR1单克隆抗体，并通过Western blot和免疫荧光验证其适用性。研究发现，CBR1在肝脏和肾脏中的表达水平与多种外源性毒素(如尼古丁代谢物)的清除效率密切相关。
---
3. **文献名称**：*"CBR1 Overexpression Promotes Doxorubicin Resistance in Breast Cancer: Insights from Antibody-Based Proteomic Profiling"*
**作者**：Gupta S, et al.
**摘要**：通过CBR1抗体进行蛋白质组学分析，揭示乳腺癌细胞中CBR1的过表达通过加速阿霉素的还原代谢导致耐药性。研究强调了靶向CBR1可能逆转化疗耐药的临床潜力。
---
如需具体文献，建议在PubMed或Web of Science中检索关键词“CBR1 antibody”或“Carbonyl Reductase 1 immunohistochemistry”获取最新研究。
×
